Details of the Drug

General Information of Drug (ID: DMPG277)

• Drug Name: KB103

Indication

Disease Entry	ICD 11	Status	REF
Dystrophic epidermolysis bullosa	EC32	Phase 2	[1]

• Cross-matching ID: TTD ID: D0B1GE

References

• [1] ClinicalTrials.gov (NCT03536143) Topical Beremagene Geperpavec (KB103) Gene Therapy to Restore Functional Collagen VII for the Treatment of Dystrophic Epidermolysis Bullosa (GEM-1). U.S. National Institutes of Health.